Skip to content

H2020HORIZONFP7

Humanitas Mirasole SpA

Country
ITItaly
Defence projects
0
Projects, all programmes
46
As coordinator
18
EU contribution (CORDIS)
EUR 22,101,728
Active
2008 to 2026

Projects

46 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
DaPhNIsRole of the Maternal Gut Microbiota in Immune Activation at the Maternal-Foetal Interface: Impact on Preeclampsia and Offspring's Immune DevelopmentH20202019CoordinatorEUR 168,277
SUMO-PCDH10Physiological consequences of Protocadherin-10 sumoylation on neuronal function.H20202019CoordinatorEUR 171,473
TRAIN-HEARTTRAIN-HEARTH20202019ParticipantEUR 522,999
BIORECARDirect cell reprogramming therapy in myocardial regeneration through an engineered multifunctional platform integrating biochemical instructive cuesH20202018ParticipantEUR 125,000
TUDCA-ALSSafety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)H20202018CoordinatorEUR 1,541,620
MONONANOCHEMIn vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancerH20202017CoordinatorEUR 168,277
ESA -ITNEuropean Sepsis Academy: towards new biomarkers to improve sepsis managementH20202016ParticipantEUR 516,123
miRCaPInnovative nanoparticle formulation for a miR-133 based treatment of cardiac hypertrophyH20202016CoordinatorEUR 150,000
EDEN2020Enhanced Delivery Ecosystem for Neurosurgery in 2020H20202016Third partyNot stated
PHIIPTX3 in Humoral Innate ImmunityH20202015CoordinatorEUR 2,497,081
NANOTAMDevelopment and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated MacrophagesH20202015CoordinatorEUR 168,277
MIROCALSEfficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patientsH20202015ParticipantEUR 450,000
PERSYSTGeneration and maintenance of long-lived memory T cells in humansH20202015CoordinatorEUR 1,500,000
MRNA IN HEARTmRNA translational regulation in heart failureH20202014CoordinatorEUR 187,415
STEPSSignalling compartmentalization and vesicle Trafficking at the Phagocytic SynapsesFP72013ParticipantEUR 343,720
STEMIMMUNEImproving adoptive T cell transfer immunotherapy for cancer with T memory stem cellsFP72012CoordinatorEUR 100,000
CARDIOEPIGENEpigenetics and microRNAs in Myocardial Function and DiseaseFP72012CoordinatorEUR 2,500,000
CNKHIVCharacterization of NK cell distributions and functions in human tissues in HIV-1 pathogenesisFP72011CoordinatorEUR 100,000
d-LIVERICT-enabled, cellular artificial liver system incorporating personalized patient management and supportFP72011ParticipantEUR 36,000
FROM BENCH TO BEDSIDERole of microRNAs 143 and 145 in cardiovascular physiology and disease: from bench to bedsideFP72011CoordinatorEUR 33,333

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.